| Price | 1,425.50p on 23-05-2025 at 18:35:04 |
|---|---|
| Change | -3.00p -0.21% |
| Buy | 1,426.00p |
| Sell | 1,425.00p |
| Buy / Sell GSK Shares | |
| Last Trade: | Sell 360.00 at 1,425.50p |
| Day's Volume: | 6,000,034 |
| Last Close: | 1,425.50p |
| Open: | 1,441.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,418.50p - 1,448.00p |
| 52wk Range: | 1,242.50p - 1,776.50p |
| Market Capitalisation: | £57,843m |
| VWAP: | 1,430.52662p |
| Shares in Issue: | 4,058m |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 360 | 1,425.50p | SI Trade Suspected SELL Trade |
16:52:25 - 23-May-25 |
| Unknown* | 13,325 | 1,425.52852p | OTC Trade |
16:36:21 - 23-May-25 |
| Sell* | 8,000 | 1,425.50p | Automatic Execution |
16:36:03 - 23-May-25 |
| Unknown* | 3,480 | 1,425.52845p | OTC Trade |
16:35:59 - 23-May-25 |
| Unknown* | 37,410 | 1,425.50p | OTC Trade |
16:35:20 - 23-May-25 |
| Unknown* | 12,817 | 1,425.50p | OTC Trade |
16:35:20 - 23-May-25 |
| Unknown* | 21,307 | 1,425.50p | OTC Trade |
16:35:20 - 23-May-25 |
| Unknown* | 927 | 1,425.50p | OTC Trade |
16:35:20 - 23-May-25 |
| Unknown* | 612 | 1,425.50p | OTC Trade |
16:35:20 - 23-May-25 |
| Unknown* | 1,018 | 1,425.50p | OTC Trade |
16:35:20 - 23-May-25 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd May 2025 12:16 pm | RNS | positive CHMP opinion on Blenrep in EU |
| 23rd May 2025 7:00 am | RNS | FDA approves Nucala COPD indication |
| 23rd May 2025 7:00 am | RNS | Transaction in Own Shares |
| 22nd May 2025 7:00 am | RNS | Transaction in Own Shares |
| 21st May 2025 7:00 am | RNS | Transaction in Own Shares |
| 20th May 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 20th May 2025 7:00 am | RNS | Transaction in Own Shares |
| 19th May 2025 7:00 am | RNS | Blenrep for 2L+ multiple myeloma approved in Japan |
| 19th May 2025 7:00 am | RNS | Transaction in Own Shares |
| 16th May 2025 7:00 am | RNS | Transaction in Own Shares |
